Tadeusz Osadnik1,2, Kamil Bujak3, Kamila Osadnik4, Hanna Czarnecka5, Natalia Pawlas4,6, Rafał Reguła3, Martyna Fronczek7,8, Mateusz Lejawa4,8, Marcin Gawlita9, Małgorzata Gonera10, Marta Góral11, Joanna Katarzyna Strzelczyk7, Marek Gierlotka3,12, Andrzej Lekston3, Janusz Kasperczyk13, Lech Poloński3, Mariusz Gąsior3. 1. 2nd Department of Cardiology and Angiology, Silesian Center for Heart Diseases, Zabrze, Poland. t.osadnik@wp.pl. 2. Chair and Department of Pharmacology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland. t.osadnik@wp.pl. 3. 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland. 4. Chair and Department of Pharmacology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland. 5. Clinical Laboratory, Silesian Center for Heart Diseases, Zabrze, Poland. 6. Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland. 7. Department of Medical and Molecular Biology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland. 8. Genomics Laboratory, Kardio-Med Silesia Science and Technology Park, Zabrze, Poland. 9. Department of Environmental Medicine and Epidemiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland. 10. Regional Specialised Hospital No. 4, Anaesthesiology and Intensive Care Unit, Bytom, Poland. 11. Students' Scientific Society, 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland. 12. Department of Cardiology, University Hospital in Opole, Faculty of Natural Sciences and Technology, Institute of Medicine, University of Opole, Poland. 13. Centre of Polymer and Carbon Materials of the Polish Academy of Sciences Zabrze, Poland.
Abstract
INTRODUCTION: Obesity is often accompanied by low-grade inflammation. In recent years a few blood-based inflammatory markers - neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and monocyte-to-high-density lipoprotein ratio (MHR) - have been identified. They have been proven to correlate well with established inflammatory markers such as hsCRP and have a prognostic value among others in patients with coronary artery disease, heart failure, and malignancies. The aim of the study was to find markers associated with obesity in young heathy adults. MATERIAL AND METHODS: The study group included 321 young healthy adults aged 18-35 years (210 males and 111 females). Partial least squares regression analysis was used to find variables associated with body mass index (BMI), except MHR. Analysed variables included complete blood count, lipid profile, sex hormone levels, acute-phase protein levels, and blood-based inflammatory markers. RESULTS: Variables with the strongest association with BMI in the group of men were HDL% and apolipoprotein B, and in the group of women, HDL, HDL%, triglycerides, and MHR. Novel inflammatory markers were not associated with BMI. We found significant (p < 0.001) correlations between novel biomarkers (NLR, dNLR) and hsCRP and fibrinogen levels in the group of subjects with obesity. CONCLUSIONS: Blood-based inflammatory markers significantly correlate with hsCRP and fibrinogen in young healthy adults with obesity, which may reflect the subclinical inflammation in this group of individuals.
INTRODUCTION:Obesity is often accompanied by low-grade inflammation. In recent years a few blood-based inflammatory markers - neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and monocyte-to-high-density lipoprotein ratio (MHR) - have been identified. They have been proven to correlate well with established inflammatory markers such as hsCRP and have a prognostic value among others in patients with coronary artery disease, heart failure, and malignancies. The aim of the study was to find markers associated with obesity in young heathy adults. MATERIAL AND METHODS: The study group included 321 young healthy adults aged 18-35 years (210 males and 111 females). Partial least squares regression analysis was used to find variables associated with body mass index (BMI), except MHR. Analysed variables included complete blood count, lipid profile, sex hormone levels, acute-phase protein levels, and blood-based inflammatory markers. RESULTS: Variables with the strongest association with BMI in the group of men were HDL% and apolipoprotein B, and in the group of women, HDL, HDL%, triglycerides, and MHR. Novel inflammatory markers were not associated with BMI. We found significant (p < 0.001) correlations between novel biomarkers (NLR, dNLR) and hsCRP and fibrinogen levels in the group of subjects with obesity. CONCLUSIONS: Blood-based inflammatory markers significantly correlate with hsCRP and fibrinogen in young healthy adults with obesity, which may reflect the subclinical inflammation in this group of individuals.
Authors: Marco Bernardi; Anna Lucia Fedullo; Barbara Di Giacinto; Maria Rosaria Squeo; Paola Aiello; Donatella Dante; Silvio Romano; Ludovico Magaudda; Ilaria Peluso; Maura Palmery; Antonio Spataro Journal: Oxid Med Cell Longev Date: 2019-11-18 Impact factor: 6.543
Authors: Jiří Trousil; Lucia Frgelecová; Pavla Kubíčková; Kristína Řeháková; Vladimír Drašar; Jana Matějková; Petr Štěpánek; Oto Pavliš Journal: Microorganisms Date: 2022-01-14